HERBALIFE LTD. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
HERBALIFE LTD. (HLF) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $10.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $10.10M, a 2.88% decline year-over-year.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $10.60M, a 8.62% decline year-over-year.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $10.90M, a 18.05% decline year-over-year.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $11.20M, a 13.85% decline year-over-year.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $44.10M, a 11.80% decline from fiscal 2024.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $50.00M, a 4.17% increase from fiscal 2023.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $48.00M, a 8.11% increase from fiscal 2022.
- HERBALIFE LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $44.40M, a 17.93% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $10.10M 10-Q · filed 2026-08-05 | $20.70M 10-Q · filed 2026-08-05 | $31.60M derived: sum of 3 quarters · filed 2026-08-05 | $42.80M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $10.60M 10-Q · filed 2026-05-06 | $21.50M derived: sum of 2 quarters · filed 2026-05-06 | $32.70M derived: sum of 3 quarters · filed 2026-05-06 | $43.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $22.10M derived: sum of 2 quarters · filed 2026-02-18 | $32.50M derived: sum of 3 quarters · filed 2026-08-05 | $44.10M 10-K · filed 2026-02-18 | |
| 2025-09-30 | $11.20M 10-Q · filed 2025-11-05 | $21.60M derived: sum of 2 quarters · filed 2026-08-05 | $33.20M 10-Q · filed 2025-11-05 | $46.50M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $10.40M 10-Q · filed 2026-08-05 | $22.00M 10-Q · filed 2026-08-05 | $35.30M derived: sum of 3 quarters · filed 2026-08-05 | $48.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $11.60M 10-Q · filed 2026-05-06 | $24.90M derived: sum of 2 quarters · filed 2026-05-06 | $37.90M derived: sum of 3 quarters · filed 2026-05-06 | $49.70M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $26.30M derived: sum of 2 quarters · filed 2026-02-18 | $38.10M derived: sum of 3 quarters · filed 2026-02-18 | $50.00M 10-K · filed 2026-02-18 | |
| 2024-09-30 | $13.00M 10-Q · filed 2025-11-05 | $24.80M derived: sum of 2 quarters · filed 2025-11-05 | $36.70M 10-Q · filed 2025-11-05 | $49.00M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2024-06-30 | $11.80M 10-Q · filed 2025-08-06 | $23.70M 10-Q · filed 2025-08-06 | $36.00M derived: sum of 3 quarters · filed 2026-02-18 | $49.70M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2024-03-31 | $11.90M 10-Q · filed 2025-04-30 | $24.20M derived: sum of 2 quarters · filed 2026-02-18 | $37.90M derived: sum of 3 quarters · filed 2026-02-18 | $49.10M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2023-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $26.00M derived: sum of 2 quarters · filed 2026-02-18 | $37.20M derived: sum of 3 quarters · filed 2026-02-18 | $48.00M 10-K · filed 2026-02-18 | |
| 2023-09-30 | $13.70M 10-Q · filed 2024-10-30 | $24.90M derived: sum of 2 quarters · filed 2024-10-30 | $35.70M 10-Q · filed 2024-10-30 | $42.60M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $11.20M 10-Q · filed 2024-07-31 | $22.00M 10-Q · filed 2024-07-31 | $28.90M derived: sum of 3 quarters · filed 2025-02-19 | $40.30M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-03-31 | $10.80M 10-Q · filed 2024-05-01 | $17.70M derived: sum of 2 quarters · filed 2025-02-19 | $29.10M derived: sum of 3 quarters · filed 2025-02-19 | $42.80M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $18.30M derived: sum of 2 quarters · filed 2025-02-19 | $32.00M derived: sum of 3 quarters · filed 2025-02-19 | $44.40M 10-K · filed 2025-02-19 | |
| 2022-09-30 | $11.40M 10-Q · filed 2023-11-01 | $25.10M derived: sum of 2 quarters · filed 2023-11-01 | $37.50M 10-Q · filed 2023-11-01 | $49.30M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | $13.70M 10-Q · filed 2023-08-02 | $26.10M 10-Q · filed 2023-08-02 | $37.90M derived: sum of 3 quarters · filed 2024-02-14 | $52.30M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | $12.40M 10-Q · filed 2023-05-02 | $24.20M derived: sum of 2 quarters · filed 2024-02-14 | $38.60M derived: sum of 3 quarters · filed 2024-02-14 | $53.20M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $26.20M derived: sum of 2 quarters · filed 2024-02-14 | $40.80M derived: sum of 3 quarters · filed 2024-02-14 | $54.10M 10-K · filed 2024-02-14 | |
| 2021-09-30 | $14.40M 10-Q · filed 2022-10-31 | $29.00M derived: sum of 2 quarters · filed 2022-10-31 | $42.30M 10-Q · filed 2022-10-31 | $55.40M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-06-30 | $14.60M 10-Q · filed 2022-08-02 | $27.90M 10-Q · filed 2022-08-02 | $41.00M derived: sum of 3 quarters · filed 2023-02-14 | $56.40M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | $13.30M 10-Q · filed 2022-05-03 | $26.40M derived: sum of 2 quarters · filed 2023-02-14 | $41.80M derived: sum of 3 quarters · filed 2023-02-14 | $54.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $28.50M derived: sum of 2 quarters · filed 2023-02-14 | $40.70M derived: sum of 3 quarters · filed 2023-02-14 | $51.00M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $15.40M 10-Q · filed 2021-11-02 | $27.60M derived: sum of 2 quarters · filed 2021-11-02 | $37.90M 10-Q · filed 2021-11-02 | $46.80M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-06-30 | $12.20M 10-Q · filed 2021-08-03 | $22.50M 10-Q · filed 2021-08-03 | $31.40M derived: sum of 3 quarters · filed 2022-02-23 | $40.60M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-03-31 | $10.30M 10-Q · filed 2021-05-04 | $19.20M derived: sum of 2 quarters · filed 2022-02-23 | $28.40M derived: sum of 3 quarters · filed 2022-02-23 | $38.30M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2019-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $18.10M derived: sum of 2 quarters · filed 2022-02-23 | $28.00M derived: sum of 3 quarters · filed 2022-02-23 | $38.60M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $9.20M 10-Q · filed 2020-11-05 | $19.10M derived: sum of 2 quarters · filed 2020-11-05 | $29.70M 10-Q · filed 2020-11-05 | $33.40M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-30 | $9.90M 10-Q · filed 2020-08-06 | $20.50M 10-Q · filed 2020-08-06 | $24.20M derived: sum of 3 quarters · filed 2021-02-17 | $35.80M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-31 | $10.60M 10-Q · filed 2020-05-07 | $14.30M derived: sum of 2 quarters · filed 2021-02-17 | $25.90M derived: sum of 3 quarters · filed 2021-02-17 | $36.30M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $15.30M derived: sum of 2 quarters · filed 2021-02-17 | $25.70M derived: sum of 3 quarters · filed 2021-02-17 | $35.50M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $11.60M 10-Q · filed 2019-10-29 | $22.00M derived: sum of 2 quarters · filed 2019-10-29 | $31.80M 10-Q · filed 2019-10-29 | ||
| 2018-06-30 | $10.40M 10-Q · filed 2019-08-01 | $20.20M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $9.80M 10-Q · filed 2019-05-02 | ||||
| 2017-12-31 | $42.10M 10-K · filed 2020-02-18 | ||||
| 2016-12-31 | $40.20M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $44.90M 10-K · filed 2018-02-22 | ||||
| 2014-12-31 | $11.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $22.30M derived: sum of 2 quarters · filed 2017-02-23 | $34.70M derived: sum of 3 quarters · filed 2017-02-23 | $45.70M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $11.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $23.44M derived: sum of 2 quarters · filed 2014-11-03 | $34.43M 10-Q · filed 2014-11-03 | ||
| 2014-06-30 | $12.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | $23.40M 10-Q · filed 2014-07-28 | |||
| 2014-03-31 | $10.99M 10-Q · filed 2014-04-28 | ||||
| 2013-12-31 | $29.50M 10-K · filed 2016-02-25 | $29.49M 10-K · filed 2014-02-18 | |||
| 2012-12-31 | $28.10M 10-K · filed 2015-02-26 | $28.13M 10-K · filed 2013-02-19 | |||
| 2011-12-31 | $24.13M 10-K · filed 2014-02-18 | ||||
| 2010-12-31 | $22.97M 10-K/A · filed 2013-12-16 | ||||
| 2009-12-31 | $20.91M 10-K/A · filed 2012-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |